Traveler’s Diarrhea
200mg tablets are indicated for the treatment of patients (≥ 12 years of age) with traveler’s diarrhea caused by noninvasive strains of Escherichia coli.

Hepatic Encephaopathy
550mg tablets are indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients 18 years of age.

Product Descriptions

Therapeutic SegmentAnti-Bacterial
FormFilm-coated Tablets